GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Sign Up For Our Newsletter

News Articles: European Medicines Agency

The European Union's drug regulator on Wednesday announced its findings into the possible connection between AstraZeneca's COVID-19 vaccine and rare blood clots.

EU Regulator: AstraZeneca Vaccine Effective; Blood Clots May Be A Rare Side Effect

The European Medicines Agency said Wednesday that blood clots should be listed as a possible but rare side effect of the AstraZeneca COVID-19 vaccine, stressing the shot's benefits outweigh the risks.

|
By:
  • Rachel Treisman